| Followers | 35 |
| Posts | 1908 |
| Boards Moderated | 0 |
| Alias Born | 11/05/2020 |
Friday, October 10, 2025 6:56:30 PM
As I see it, they aren't pointing out human proof of concept when it comes to safety or efficacy (at least not that post). What they are pointing out is that it doesn't even work safely on the most basic level.
The FDA doesn't care that Harriet the Horse can open her eye because of IsoPet. It means nothing.
IsoPet and RadioGel (US and India) at this very point in time are three (3) completely different products. A radioisotope is not the same thing as manufacturing aspirin and stocking a shelf all across the globe.
Korenko isn't stupid. He knew back in 2016 to focus on IsoPet because it is nothing like getting an FDA approval. It's a great ploy to string people along. And it has so many people fooled here. And now that the FDA has rejected him twice since 2021, he needs another avenue to string people along. Cue India.
There is nothing circular about their argument. It's a wonderfully orchestrated "scam" at this point in time.
The FDA doesn't care that Harriet the Horse can open her eye because of IsoPet. It means nothing.
IsoPet and RadioGel (US and India) at this very point in time are three (3) completely different products. A radioisotope is not the same thing as manufacturing aspirin and stocking a shelf all across the globe.
Korenko isn't stupid. He knew back in 2016 to focus on IsoPet because it is nothing like getting an FDA approval. It's a great ploy to string people along. And it has so many people fooled here. And now that the FDA has rejected him twice since 2021, he needs another avenue to string people along. Cue India.
There is nothing circular about their argument. It's a wonderfully orchestrated "scam" at this point in time.
Recent RDGL News
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
